echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Seeing through the "trick" of cancer cells brings new hope to patients with colorectal cancer

    Seeing through the "trick" of cancer cells brings new hope to patients with colorectal cancer

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Colon cancer is a malignant tumor of the digestive tract that occurs in the colon of the human body, mostly in the age of 40-50
    .
    With the development of society, people’s living habits have gradually undergone tremendous changes under the influence of a variety of foreign cultures.


    Their preference for heavy tastes, high-sugar and high-fat diets, hunger and satiety, unclean diets, and staying up late all make the incidence of colon cancer increasing.




    Recently, the top academic journal "Nature" published three consecutive heavy articles that debunked the "trick" of cancer cells and provided new prevention strategies for people at high risk of colon cancer
    .
    At the same time, "Nature" also published an online News & Views titled Cancer stem cells in the gut have a bad influence on neighbouring cells, providing important insights into the dynamics of competition between cancer cells and their neighboring cells in the intestine


    .




    As we all know, stem cells are a type of cells with infinite or immortal self-renewal ability that can produce at least one type of highly differentiated progeny cells.
    If cancer stem cells in the body are not completely eliminated, mutated intestinal stem cells will It will "instigate" surrounding healthy cells and inhibit the activity of surrounding healthy intestinal stem cells, allowing cancer to recur and metastasize


    .




    The adenomatous polyposis colon (APC) gene in stem cells, as a tumor suppressor gene for colorectal cancer, is the most common site of germline and somatic mutations
    .
    When this gene is mutated, it will induce the phosphorylation and degradation of β-catenin, negatively regulate the WNT pathway, and induce colon cancer


    .




    In recent years, with the advancement of technologies such as deep-targeted DNA sequencing, researchers have noticed that cancer-related mutant genes have already been latent in normal human tissues
    .
    Therefore, in order to explore the interaction between cancer-promoting mutant cells and normal neighboring cells, researchers at the Cambridge Stem Cell Institute developed a microscopy technique that uses multicolor labeling technology to track the trajectories of single mutant genes Kras and Pik3ca , Studies have found that mutated cancer stem cells can secrete specific cytokines and inhibit the activity of surrounding healthy intestinal stem cells


    .




    Of course, the research process of researchers does not stop there
    .
    Researchers from Cancer Research UK have established an in vitro cell culture system that allows single cells to develop into "small intestinal organoids" in an in vitro environment to assess the viability of stem cells


    .



    Excitingly, the experiment found the key vector of Apc mutation, "NOTUM gene".
    Compared with normal cells, this gene showed higher expression in the Apc mutant cell lineage and can be used to prevent Apc mutant colorectal.
    It is a cancer target and can inhibit NOTUM through genetic or drug means, thereby inhibiting the expansion of Apc mutant cells and the formation of intestinal adenomas
    .



    In order to further study the mechanism of the interaction between normal and malignant stem cells, researchers at the University of Amsterdam Medical Center in the Netherlands built mouse and human bowel cancer models mediated by Apc gene inactivation and found that APC-mediated β-catenin is one This kind of gene expression regulator that helps maintain the state of intestinal stem cells will actively inhibit the growth of neighboring cells and even induce the apoptosis of wild-type intestinal stem cells
    .


    Moreover, cancer stem cells carrying Apc mutations have a stronger competitive advantage compared to normal stem cells.
    This advantage is due to the ability of Apc mutant cells to secrete WNT antagonists, which not only inhibits the activity of normal stem cells, but also promotes their differentiation
    .
    The latest research has found that lithium chloride can eliminate the inhibitory effect of WNT antagonists, providing a new strategy for the prevention of bowel cancer
    .



    So far, the focus of medical research in the field of cancer has been on the promotion of immune system-mediated defenses
    .
    However, the importance of stem cells and tissue environment to tumors is slowly being explored.
    In future further research, if the WNT signaling pathway can be restarted and the function of NOTUM can be restricted in mouse models of Apc gene mutations, it is expected Inhibit the occurrence and development of tumors
    .



    All in all, these three breakthrough studies provide new ideas for future cancer treatments, which can eliminate the competitive advantage of cancer by inhibiting the differentiation of malignant tumor stem cells.
    In the future, scientists are expected to develop new anti-cancer therapies based on this feature.

    .
    (Biological Exploration)



    Reference materials:



    1.
    https://#citeas



    2.
    https://#citeas


    3.
    https://#ref-CR1


    4.
    https://


    5.
    https://mp.
    weixin.
    qq.
    com/s/UvzRmo4NuPkWKBoJh8aokg

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.